The National Pharmaceutical Pricing Authority (NPPA) on October 23, 2026, issued FAQs regarding the implementation of the TMR Order.
The following has been stated: -
•The National Pharmaceutical Pricing Authority (NPPA) has issued FAQs clarifying compliance requirements under the TMR Order, including submission of Form V and Annexure-I through the IPDMS portal within seven days of publication, irrespective of changes in MRP.
•Manufacturers must advertise products with reduced prices, disclose pre-revised and revised MRPs, and submit Patient Assistance Programme undertakings before October 29, 2026.
•Information specified under notes q(iii) and q(iv) may be submitted by November 09, 2026, with q(iv) information as of October 31, 2026.
•Recall, relabelling, or restickering of existing stocks is not mandatory if retailer-level price compliance is ensured.
•Revised prices take effect from November 09, 2026, and eligibility for annual price increases under Paragraph 20(1) of DPCO, 2013, depends on MRP revision and the date of the last revision.
The detailed notification is given in the document below.
